← back to search

Marie Duhamel

La Ligue Contre le Cancer · FR
Area of research
Immunology · Genetics
Research interest
Research interests include Immune cells in cancer, Glioma Diagnosis and Treatment, Advanced Proteomics Techniques and Applications, and Ubiquitin and proteasome pathways.
h-index
19
citations
1,040
works
83
NIH funding
primary concept
Biology
email

Recent publications

Distinct tumor immune microenvironmental landscapes drive divergent immunotherapy responses in glioblastoma
Neuro-Oncology 2026cited by 0position: middledoi
Real-time glioblastoma tumor microenvironment assessment by SpiderMass for improved patient management
Cell Reports Medicine 2024cited by 27position: middledoi
Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop
Cancer Cell 2022cited by 147position: middledoi
Anticancer immunotherapies transition postcapillary venules into high-endothelial venules that generate TCF1+ T lymphocyte niches through a feed-forward loop
bioRxiv (Cold Spring Harbor Laboratory) 2021cited by 1position: middledoi
Paclitaxel Treatment and Proprotein Convertase 1/3 (PC1/3) Knockdown in Macrophages is a Promising Antiglioma Strategy as Revealed by Proteomics and Cytotoxicity Studies
Molecular & Cellular Proteomics 2018cited by 24position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Gabriele Bergers · VIB-KU Leuven Center for Cancer Biology3 papers (2021–2026)Florian Rambow · Heinrich Heine University Düsseldorf2 papers (2021–2022) · 2 papers (2018–2024)Thomas Hehlgans · University of Regensburg2 papers (2021–2022)Giuseppe Floris · Twitter (United States)2 papers (2021–2022)Yichao Hua · Nanjing Medical University2 papers (2021–2022)Steffie Junius · KU Leuven2 papers (2021–2022)Susan Schlenner · Rega Institute for Medical Research2 papers (2021–2022)Damya Laoui · Vrije Universiteit Brussel2 papers (2021–2022)Diether Lambrechts · Center for Human Genetics2 papers (2021–2022)Gerlanda Vella · VIB-KU Leuven Center for Cancer Biology2 papers (2021–2022)Adrian Liston · University of Cambridge2 papers (2021–2022)Elizabeth Allen · Oxurion (Belgium)2 papers (2021–2022)Asier Antoranz · VIB-KU Leuven Center for Cancer Biology2 papers (2021–2022)David Nittner · VIB-KU Leuven Center for Cancer Biology2 papers (2021–2022)Ann Smeets · Universitair Ziekenhuis Leuven2 papers (2021–2022)Jean‐Christophe Marine · Cancer Research UK2 papers (2021–2022)Francesca M. Bosisio · VIB-KU Leuven Center for Cancer Biology2 papers (2021–2022)Stefanie Dimmeler · California Institute for Regenerative Medicine2 papers (2021–2022)Pascal Merchiers · Mission Therapeutics (United Kingdom)2 papers (2021–2022)